26 results match your criteria: "IRCCS Hospital Galeazzi-Sant'Ambrogio[Affiliation]"
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets.
J Clin Med
March 2023
Department of Clinical and Experimental Medicine, Division of Cardiology, AOU Policlinico G. Martino, University of Messina, 98122 Messina, Italy.
Article Synopsis
- * Lipoprotein(a) (Lp(a)) has been identified as a key factor predicting adverse outcomes after ACS, leading to the development of new therapies that can lower Lp(a) levels and improve long-term outcomes.
- * Recent research highlights the roles of inflammation, gut microbiome, and novel targets in secondary prevention strategies, suggesting a need for personalized approaches in managing high-risk patients post-ACS.